Also trades as: INDIAGLYCO.NS (NSE) · $vol 2M
INDIAGLYCO.BO BSE
India Glycols Limited
1W: -3.3%
1M: +29.9%
3M: -72.2%
YTD: -69.9%
1Y: -62.7%
3Y: -4.2%
5Y: -11.7%
₹305.75 ($3.18)
+7.15 (+2.39%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$42.1B
+11.8% ▲
5Y CAGR: +12.9%
Gross Profit
$8.6B
-13.8% ▼
5Y CAGR: +4.1%
Operating Income
$4.9B
+100.8% ▲
5Y CAGR: +20.5%
Net Income
$2.9B
+26.8% ▲
5Y CAGR: +17.3%
EPS (Diluted)
$45.95
+23.2% ▲
5Y CAGR: +1.6%
EBITDA
$7.0B
+37.0% ▲
5Y CAGR: +19.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $28.7B | $26.4B | $32.9B | $37.7B | $42.1B |
| YoY Growth | +25.2% | -8.1% | +24.9% | +14.4% | +11.8% |
| Cost of Revenue | $19.7B | $15.8B | $27.8B | $27.7B | $33.5B |
| Gross Profit | $8.5B | $10.7B | $10.6B | $10.0B | $8.6B |
| Gross Margin | 29.5% | 40.5% | 32.0% | 26.5% | 20.4% |
| R&D Expenses | $47M | $44M | $0 | $0 | $0 |
| SG&A Expenses | $2.3B | $1.1B | $1.3B | $1.2B | $3.7B |
| Operating Expenses | $5.3B | $914M | $2.0B | $7.5B | $3.7B |
| Operating Income | $1.8B | $9.4B | $3.2B | $2.5B | $4.9B |
| Operating Margin | 6.4% | 35.6% | 9.7% | 6.5% | 11.7% |
| Interest Expense | $697M | $1000M | $1.2B | $1.6B | $1.7B |
| Income Before Tax | $3.7B | $1.6B | $2.2B | $2.9B | $3.8B |
| Tax Expense | $394M | $240M | $503M | $614M | $844M |
| Net Income | $3.4B | $1.3B | $1.7B | $2.3B | $2.9B |
| Net Margin | 11.8% | 4.7% | 5.3% | 6.1% | 7.0% |
| EPS (Diluted) | $54.89 | $20.20 | $27.94 | $37.29 | $45.95 |
| EBITDA | $5.0B | $3.5B | $4.3B | $5.1B | $7.0B |
| Shares Outstanding | 31M | 31M | 31M | 31M | 64M |